Dr. Barkat Charania Joins the Writing Staff of Cancer.im

Photo of author

(Newswire.net — November 29, 2013) Springville, UT — 


Cancer.im is proud to announce that Dr. Barkat Charania has joined the Cancer.im writing staff.


A lifelong cancer patient advocate and orthopedic surgeon of more than 30 years, Dr. Charania has served as a consultant to WHO, UNICEF and International Council for Control of Iodine Deficiency Disorders (IDD). He managed the eradication of IDD project from 1979-90, a collaborative effort of UNICEF, AKDN and NIH. He served on the faculty of Aga Khan University, taught at Postgraduate College of Physicians and Surgeons, and was invited to be guest lecturer at Institute of Business Administration and as Keynote speaker at National Iodine Deficiency Disorders (IDD) seminars.


Dr. Barkat Charania is acutely inquisitive about the meaning of our existence on the earth.  He writes about Health Solutions, Logic, Philosophy and Sufism. Most of his writing is based on simple logic and common sense. After practicing allopathic medicine for over three decades, he is an advocate of preventative medicine.  He believes the effects of diseases can be limited by eating right foods; He quotes Hippocrates 400 B.C “Let food be thy medicine and medicine be thy food.”


His writing skills and vast medical practice experience are a great addition to the Cancer.im goals of educating cancer patients and their caretakers. To learn more about Dr. Charania and his contribution to cancer please visit his profile at http://cancer.im/profile/BarkatCharania



About Cancer.im

In 2013, nearly 1.6 million Americans will be diagnosed with cancer. Of that, 581,000 people are expected to die.  Cancer accounts for 1 in every 4 deaths, second only to heart disease as the most common cause of death. The monetary cost seems irrelevant to the loss of life. Overall costs of cancer are projected to exceed $201 billion in 2013: $77 billion for direct medical costs (all health expenditures) as well as over $124 billion for the indirect mortality costs.


Cancer.im is a nonprofit organization with its mission to empower every cancer patient, regardless of their ability to pay, with the ability to research their disease and to find, organize, and manage their own cancer support network. The goal of these support networks is to assist the patient in conserving needed energy by reducing the burden associated with their own daily trials and tribulations. Cancer.im strives to convert this saved energy into a higher level of patient activity and a stronger determination to fight.


Cancer.im vision is based in part on the Robert Ryan Cancer Protocol – a modular 15 part best practice guide on teaching and assisting cancer patients and their loved ones on the importance of Quality of Life (QoL) and how to raise it when managing a diagnosis of cancer. 

One weapon on this war on cancer is Quality of Life (QoL). On October 27, 2007 Dr. Nikolaou, on behalf of Fox Chase Medical Center (a National Comprehensive Cancer Network) published a double blind placebo controlled study titled “Quality of Life (QOL) Supersedes the Classic Predictors of Survival in Locally Advanced Non-Small Cell Lung Cancer (NSCLC).”  The study was designed to evaluate the role of QoL as a prediction for survival. Some 91 percent of patients completed a standardized QoL survey before treatment. All patients were followed for at least 17 months. What they found is quality of life emerged as the most significant predictor of overall patient survival.


 “…We conducted two different statistical analyses including all the usual prognostic factors and either way, quality of life remained the strongest predictor of overall  survival,”“…What’s more, if a patient’s quality of life increased over time, we saw a  corresponding increase in survival,” said Dr. Benjamin Movsas of Henry Ford Hospital. This study concluded that by raising a Cancer Patients Quality of Life via the European Organization for Research and Treatment of Cancer QLQ-C30, you could directly lower the incidence of morbidity in a cancer patient, regardless of treatment.






1867 East 1225 South
Springville, UT 84663